Immunosensors: technology and opportunities in laboratory medicine

Area of Science:

• Biomedical Engineering
• Analytical Chemistry

Background:

• Immunosensors detect molecular binding using antigen/antibody pairs and signal transducers.
• Indirect immunosensors (heterogeneous) use labeled species, while direct immunosensors (homogeneous) detect binding via physical property changes.
• Direct immunosensors enable real-time antigen-antibody reaction monitoring but face challenges with nonspecific binding.

Purpose of the Study:

• To review the principles, advantages, limitations, and applications of direct and indirect immunosensors.
• To highlight the potential of direct immunosensors for sensitive molecular detection.
• To discuss the current commercial landscape and future prospects of immunosensor technology.

Main Methods:

• Review of existing literature on immunosensor technologies.
• Analysis of direct and indirect immunoassay principles.
• Comparison of sensor performance, including detection limits and real-time capabilities.

Main Results:

• Immunosensors can detect molecules with high sensitivity (10^-9 to 10^-13 mol/L).
• Direct immunosensors provide real-time monitoring, a key advantage over indirect methods.
• Despite their benefits, direct immunosensors have limited commercial success, with optical types being the exception.

Conclusions:

• Direct immunosensors offer significant advantages for real-time molecular detection.
• Overcoming challenges like nonspecific binding is crucial for broader commercial adoption.
• Further development is needed to expand the successful applications of direct immunosensor technology.